Justin Lyman
Rheumatology · Lake Charles, LANPI 1376540393
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $847 and has fallen 54.9% since, to $382 in 2023. That places this record below the midpoint for rheumatology clinicians in LA, where the typical reported total is $8,351.
Across 85 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$398
- Pfizer$239
- AstraZeneca$148
- Regeneron Healthcare Solutions, Inc.$135
- Bayer$117
- Amgen$110
- plus $602 from 14 others
What the payments were for
- Food & beverage$1,73699%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $398 |
| Pfizer | 12 | $239 |
| AstraZeneca | 8 | $148 |
| Regeneron Healthcare Solutions, Inc. | 4 | $135 |
| Bayer | 6 | $117 |
| Amgen(2 entities) | 6 | $110 |
| GSK | 6 | $107 |
| Mylan Specialty L.p. | 4 | $99 |
| ANI Pharmaceuticals, Inc. | 3 | $59 |
| Johnson & Johnson | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Baxter Healthcare | 1 | $43 |
| Lilly USA, LLC | 2 | $35 |
| UCB, Inc. | 1 | $35 |
| Boehringer Ingelheim | 1 | $33 |
| Sanofi | 1 | $21 |
| Novartis | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Shionogi Inc | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
How this compares
$1,749 in reported general payments places this provider in the 20th percentile of 88 rheumatology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 16 | $234 |
| Gabapentin | 18 | $187 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Lake Charles
- Enrique MendezLake Charles$29K
- Gurjot BasraLake Charles$14K
- Aaron BroadwellShreveport$1.6M
- Ladislas LazaroLafayette$265K
- Jerry PoundsMetairie$252K
- Carl GauthierHammond$219K
- Malik SpadyCovington$160K
- Sean ShannonBaton Rouge$157K
- Stephen LindseyBaton Rouge$130K
- Agnes SolonAlexandria$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.